These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The effect of femoral component design on patellar tracking in total knee arthroplasty: Genesis II prosthesis versus Vanguard prosthesis.
    Author: Kong CG, Park SW, Yang H, In Y.
    Journal: Arch Orthop Trauma Surg; 2014 Apr; 134(4):571-6. PubMed ID: 24515865.
    Abstract:
    INTRODUCTION: The Genesis II knee system incorporates 3° of external rotation into the femoral component and the femoral component is implanted in neutral rotation to the femur. The purpose of this study was to compare patellar tracking of the Genesis II knee system with that of the Vanguard knee system, in which the femoral component is routinely implanted in a 3° externally rotated position to the posterior condylar axis (PCA) of the femur. MATERIALS AND METHODS: One hundred consecutive knees scheduled to undergo total knee arthroplasty (TKA) were enrolled. Fifty knees underwent TKA with the posterior-stabilized (PS) Genesis II prosthesis and 50 knees underwent TKA with the PS Vanguard prosthesis. Rotation of the femoral component was calculated by measuring the acute angle between the transepicondylar axis (TEA) and the PCA on axial computed tomography (CT) images. The postoperative patellar tilt and displacement were compared between groups. The range of motion and Knee Society scores were also compared. RESULTS: Forty-eight knees in each group were followed up for 2 years. There was no difference in the angle between the PCA and the TEA on postoperative CT scans between the two designs. There was also no difference in patellar tracking between groups. Both the Genesis II and Vanguard knee systems showed good clinical results at 2 years postoperatively. CONCLUSION: The patellar tracking of the Genesis II prosthesis was comparable to that of the Vanguard prosthesis. LEVEL OF EVIDENCE: Prospective cohort study, Level II.
    [Abstract] [Full Text] [Related] [New Search]